Tech Company Financing Transactions
Oculus Innovative Sciences Funding Round
Oculus Innovative Sciences closed a $29.2 million funding round on 3/31/2006. Investors included Western Technology Investment.
Transaction Overview
Company Name
Announced On
3/31/2006
Transaction Type
Debt
Amount
$29,200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1129 North McDowell Blvd.
Petaluma, CA 94954
USA
Petaluma, CA 94954
USA
Phone
Website
Email Address
Overview
Oculus Innovative Sciences (NASDAQ: OCLS), is an emerging specialty pharmaceutical company focused on the development, manufacture and marketing of a family of products intended to help prevent and treat infection in acute and chronic wounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Schutz
Chief Financial Officer
Robert Miller
Executive Vice President
Bruce Thornton
Browse more venture capital transactions:
Prev: 3/31/2006: TagWorld venture capital transaction
Next: 3/31/2006: Bantek West venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs